ETHOS Launches Alumni Organization to Connect Clients in a Supportive Environment After Program Completion

ETHOS Treatment LLC, a leading provider of care for individuals and families dealing with substance use disorders and mental health issues, is proud to announce the launch of its Alumni Organization. Introduced in May 2024, this initiative aims to cultivate a supportive and interconnected network among clients, extending beyond their program completion. 

Gathering monthly via Google Meet, participants will have the opportunity to share experiences, maintain connections, and most importantly, establish a robust support system for those still on their wellness journey. This accessible and convenient platform ensures that all alumni, regardless of location, can benefit from this supportive community.

Meetings are held on the second Wednesday of each month, 7:30 PM – 8:30 PM EST.  

Michael Blanche, LCSW, Co-Founder and Chief Clinical Officer at ETHOS, emphasizes the unique approach of the Alumni Organization: “Our alumni group stands out by offering a standalone community that respects the diverse paths to recovery and wellness, free from affiliations with specific 12-step fellowships or self-help groups,” said Blanche. “Whether you’ve just completed one of our programs or have been on your journey for some time, it’s a space to share experiences, celebrate milestones, and forge meaningful connections with fellow alumni.” 

For more information, visit https://www.ethostreatment.com

ETHOS Treatment LLC Earns LegitScript Certification

ETHOS Treatment LLC is proud to announce it has earned LegitScript certification, which recognizes the organization’s commitment to transparency and compliance with applicable laws and regulations for the healthcare industry.

LegitScript is the only certification and monitoring service for U.S. drug and alcohol addiction treatment providers that is relied on by Google, Microsoft, and Facebook to vet advertisers for eligibility.

“In 2018, these online platforms suspended addiction treatment ads, but now drug and alcohol addiction treatment providers can resume online advertising by being LegitScript certified,” said ETHOS Director of Marketing Samantha L. Osterlof, MS, CRS, CFRS.

Certification is a recognized seal of approval that enables businesses to showcase their compliance, unlock opportunities to advertise, and accept digital payments.

“Being LegitScript Certified also builds trust with patients by letting them know we operate safely and legally,” concluded Osterloff. “The certification helps differentiate our services from both legitimate competitors and addiction treatment providers that are involved in illicit activities.”

ETHOS Treatment’s Cait Kish Honored with Caron Foundation Unsung Hero Award 

ETHOS Treatment’s Cait Kish Honored with Caron Foundation Unsung Hero Award 

ETHOS Treatment LLC proudly announces Cait Kish has been awarded the Unsung Hero Award from the Caron Foundation. The award was presented during the 22nd Annual Greater Philadelphia Community Awards Breakfast, an event dedicated to recognizing individuals who have made significant, selfless contributions to raising awareness, promoting prevention, and delivering treatment as an alternative to the pain of addiction to alcohol and other drugs.

“Cait supports women on their journeys, creating a safe environment for confronting past experiences,” said ETHOS Co-founder and Chief Clinical Officer Michael Blanche. Her leadership sets a standard of excellence for specialized care, reflecting ETHOS’ commitment to helping people, help people.” 

Cait has played a pivotal one of ETHOS’ signature programs, the Women’s Dual Diagnosis Trauma Track. She is a Board-Certified Music Therapist, Licensed Professional Counselor, and Certified Clinical Trauma Professional with over a decade of experience in mental health and substance abuse. 

“We are incredibly proud of Cait and her contributions to the Women’s Dual Diagnosis Trauma Track,” added Blanche. “Her compassion, understanding, dedication, and empathetic approach have made a difference in the lives of many women on their healing journeys.”

ETHOS Treatment Adds Two Executives to Leadership Team

Michael Santoro named Vice President of Finance; Katelyn Fisher appointed Director of Operations

ETHOS Treatment, LLC, a leading provider of care for individuals and families who struggle with substance use disorder and/or mental health issues, is pleased to announce the addition of two executives. Michael Santoro has been named Vice President of Finance, and Katelyn Fisher has been named Director of Operations. As members of the leadership team, Santoro and Fisher will help drive the organization’s growth and development as the region’s premier Intensive Outpatient Programs provider.

“We are thrilled to welcome Michael to the team,” said co-founder and CCO, Michael Blanche MSS, LCSW, “His deep understanding of financial management and strategic planning will be instrumental as we continue to grow and enhance our services to meet the evolving needs of our clients.”

Santoro has more than 15 years of experience in accounting and finance across diverse industries, serving in roles of increasing responsibility with companies ranging from $700M to $2B in revenue.

Fisher also brings a wealth of experience and expertise to her new position, including seven years in client-facing roles supporting children and adolescents on the autism spectrum. As Director of Operations, she is committed to leveraging her expertise to drive organizational excellence and ensure the delivery of high-quality services to those in need.

“Kate’s multifaceted experience across client care, intake, billing, and operations, along with her adaptability and strategic mindset, have equipped her with a holistic understanding of the behavioral health landscape,” added Blanche.

Santoro earned a B.S. in Accounting from Saint Joseph’s University and an MBA in Finance from Boston College. Fisher holds a bachelor’s degree in psychology from Bloomsburg University.

ETHOS Treatment LLC Expands Programs to Include Services for Adolescent Patients at its Reading-area Location in Wyomissing

​​ETHOS Treatment LLC, a leading provider of care for individuals and families who struggle with substance use disorder and/or mental health issues, is expanding its programs to include services for adolescent patients at its Reading-area location in Wyomissing.

“There is a pressing need for specialized care tailored for individuals aged 13-18,” said Dan Appel MAMS, the clinician who will lead this program. “Treating adolescents has become more complicated over the last 10-20 years in part due to technology, social media, and other social pressures, but the good news is it has also become much more socially acceptable to seek treatment.”

The Adolescent Intensive Outpatient Program (IOP) at ETHOS will offer weekly groups of 10 individuals. This small-group setting ensures a supportive environment where adolescents can engage meaningfully with their peers and receive the attention they deserve from experienced therapists.

“Research shows the importance of downregulating the nervous system, and we work to give adolescents the tools to achieve this. There has always been a need for this population, and until now there have not been enough resources in Berks County,” said Co-Founder and CCO Michael Blanche, MSS, LCSW. 

The IOP for adolescents at ETHOS offers an array of services tailored to meet each patient’s unique needs. The program includes thorough assessments, individual and small group therapy sessions, and family therapy, recognizing the importance of family support and involvement in the recovery process. 

“Our unique IOP approach helps clients overcome obstacles and ensures they benefit from needed structure, stability, consistency, and accountability,” added Blanche.   

ETHOS also coordinates closely with schools and school-mandated substance use treatment programs and provides psychiatric assessments. 

“Our patients have school and family obligations, so outpatient therapy enables them to meet the demands of normal life and apply the skills they learn in real-world settings,” concluded Appel. “This can be a life-changing experience, as we aim to blunt issues before individuals reach adulthood, bringing happiness into our patients’ lives.”  

Currently, there is no waitlist for adolescents throughout the ETHOS Treatment LLC system. Contact us today at 267-669-0300. 

Mike Flanagan Named Senior Vice President, Business Development  to Support Ongoing Rapid Growth

Mike Flanagan Named Senior Vice President, Business Development to Support Ongoing Rapid Growth

Healthcare executive brings more than 20 years of experience to one of the region’s fastest-growing behavioral health organizations

PLYMOUTH MEETING, PA (March 4, 2024) — ETHOS Treatment, LLC has named Mike Flanagan Senior Vice President of Business Development. The Company has experienced rapid expansion, growing to seven locations, telehealth services, and over 40 counselors in the past few years.  Flanagan will continue to drive ETHOS’ growth as the Company executes plans to expand into new markets throughout the Mid-Atlantic and U.S in the coming years.

“With his deep expertise in healthcare, particularly around innovation, business planning, and growth strategies, Mike adds a whole new dimension to our leadership team,” said Brendan Young, CEO and co-founder. “The growth we have been experiencing is great confirmation of our disruptive model, and we are just getting started.  He will play a critical role as we continue our rapid expansion into new markets, delivering the type of care our clients need, when they need it.”

ETHOS has a unique, disruptive model for the delivery of Intensive Outpatient Programs (IOP).  IOP are an alternative to inpatient services for patients who do not require a full-time, facility treatment regimen. Some of the main benefits of IOP are cost compared to inpatient services, which can be 10 times or more, along with the patient’s ability to receive services while still in their real-life settings. 

“Some IOP programs have been the subject of negativity in a few markets around out-of-network and questionable billing practices, and counselor burnout,” added Young.  “ETHOS’ disruptive model is designed to ensure clients receive timely assistance in overcoming obstacles and benefit from needed structure, stability, consistency, and accountability. The Company does this by aggressively investing in the people providing care, putting them in the best position to deliver the best experience and outcomes to the patient.”

“Our goal is to interrupt self-destructive routines with healthy ones, breaking the cycle of a mental health or substance use issue,” added Michael Blanche, Chief Clinical Officer and co-founder, “And like you or I, our clients have school, work, and family obligations, so outpatient therapy enables them to meet the demands of normal life and apply the skills they learn in real-world settings. We do this through a disruptive model that supports everyone in the process, counselors, non-clinical staff, and patients, where we are helping people help people.”

With outpatient treatment centers in Philadelphia, West Chester, Plymouth Meeting, Collegeville, Broomall, Jenkintown, Wyomissing and Telehealth, ETHOS helps adults and adolescents with mental health issues and substance use disorders through IOP, individual counseling, small group, and family therapy, all of which maximize the potential for long-term, sustainable recovery.  Several locations also offer specialty programs for people with gambling disorders, eating disorders, as well as groups specifically for first responders and people who have experienced trauma.

“The ETHOS mission of ‘helping people help people’ truly resonates with me and is an incredible value proposition in the market,” Flanagan said.  “Our differentiated, people-centric model that allows clinicians to focus on high-quality care that best supports our patients’ healing journeys is a mission I am thrilled to be a part of and help grow.”

Prior to joining ETHOS, Flanagan was Vice President of Strategic Initiatives and Growth at Change Healthcare and a Vice President/General Manager at McKesson Corporation. Earlier, Flanagan was part of the senior team that led Portico Systems and positioned the company for acquisition by McKesson. 

“Mike is a metrics- and data-driven professional who understands how to scale mission-based organizations,” said Ned Moore, Board Member and co-founder. “His diverse background in healthcare including financial management, product development, and go-to-market strategies gives him a unique lens through which to help us grow our truly unique model and serve our clients as they work to achieve long-term, sustainable recovery.”